Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
| General Information of Drug (ID: DR2304) | ||||||
|---|---|---|---|---|---|---|
| Drug Name |
Resorcinol
|
|||||
| Synonyms |
Developer O; Developer R; Developer RS; Dihydroxybenzol; Benzene, 1,3-dihydroxy-; Benzene, m-dihydroxy-; Durafur developer G; Fouramine RS; Fourrine 79; Fourrine EW; Nako TGG; Pelagol Grey RS; Pelagol RS; Phenol, m-hydroxy-; Rcra waste number U201; Resorcin; Resorcine; Resorcino; Resorcinolum; Resorzin; Rezamid; Sulforcin; benzene-1,3-diol; m-Benzenediol; m-Dihydroxybenzene; m-Dioxybenzene; m-Hydroquinone; m-Hydroxyphenol; resorcinol; 1,3-Benzenediol; 1,3-Dihydroxybenzene; 108-46-3; 3-Hydroxyphenol; C.I. Developer 4; C.I. Oxidation Base 31
|
|||||
| Indication | Discovery agent | Investigative | [1] | |||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
| Pharmaceutical Properties | Molecular Weight | 110.11 | Topological Polar Surface Area | 40.5 | ||
| Heavy Atom Count | 8 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 2 | |||
| Cross-matching ID | ||||||
| The Metabolic Roadmap of This Drug | |||||
|---|---|---|---|---|---|
| The Full List of Drug Metabolites (DM) of This Drug | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
| The Full List of Metabolic Reaction (MR) of This Drug | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
| Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.


